0000899243-20-003457.txt : 20200206 0000899243-20-003457.hdr.sgml : 20200206 20200206070015 ACCESSION NUMBER: 0000899243-20-003457 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200130 FILED AS OF DATE: 20200206 DATE AS OF CHANGE: 20200206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashworth Richard M CENTRAL INDEX KEY: 0001617806 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36759 FILM NUMBER: 20580854 MAIL ADDRESS: STREET 1: 200 WILMOT ROAD CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Walgreens Boots Alliance, Inc. CENTRAL INDEX KEY: 0001618921 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 471758322 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 108 WILMOT ROAD CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: (847) 315-2500 MAIL ADDRESS: STREET 1: 108 WILMOT ROAD CITY: DEERFIELD STATE: IL ZIP: 60015 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-01-30 0 0001618921 Walgreens Boots Alliance, Inc. WBA 0001617806 Ashworth Richard M WALGREENS BOOTS ALLIANCE, INC. 108 WILMOT ROAD DEERFIELD IL 60015 0 1 0 0 SVP, President of Walgreen Co. Common Stock 74541 D Employee Stock Option (Right to Buy) 35.65 2014-09-01 2021-09-01 Common Stock 9921 D Employee Stock Option (Right to Buy) 35.50 2015-11-01 2022-11-01 Common Stock 15898 D Employee Stock Option (Right to Buy) 60.52 2016-11-01 2023-11-01 Common Stock 12398 D Employee Stock Option (Right to Buy) 64.22 2017-11-01 2024-11-01 Common Stock 40283 D Employee Stock Option (Right to Buy) 84.68 2018-11-01 2025-11-01 Common Stock 37209 D Employee Stock Option (Right to Buy) 82.46 2019-11-01 2026-11-01 Common Stock 56337 D Employee Stock Option (Right to Buy) 67.01 2027-11-01 Common Stock 61910 D Employee Stock Option (Right to Buy) 79.90 2028-11-01 Common Stock 47407 D Employee Stock Option (Right to Buy) 57.38 2029-11-01 Common Stock 50420 D Employee Stock Option (Right to Buy) 52.28 2030-01-29 Common Stock 26162 D Includes shares underlying restricted stock units ("RSUs") granted under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan"), and shares underlying restricted stock units issued in lieu of dividends (through January 30, 2020) on outstanding restricted stock units, which were granted and vest as follows: (a) 19,535 RSUs granted on September 1, 2019 that vest with respect to 9,767 shares on September 1, 2020 and with respect to 9,768 shares on September 1, 2021; (continued in footnote 2) (continued from footnote 1) (b) 7,657 RSUs granted on November 1, 2019 and that vest with respect to 2,549 shares on November 1, 2020, with respect to 2,550 shares on November 1, 2021 and with respect to 2,558 shares on November 1, 2022; and (c) 4,782 RSUs granted on January 29, 2020 and that vest with respect to 1,592 shares on January 29, 2021, with respect to 1,592 shares on January 29, 2022 and with respect to 1,598 shares on January 29, 2023. The option vests with respect to 20,616 shares on November 1, 2018, with respect to 20,616 shares on November 1, 2019, and with respect to 20,678 shares on November 1, 2020, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. The option vests with respect to 15,786 shares on November 1, 2019, with respect to 15,787 shares on November 1, 2020, and with respect to 15,834 shares on November 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. The option vests with respect to 16,789 shares on November 1, 2020, with respect to 16,790 shares on November 1, 2021, and with respect to 16,841 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. The option vests with respect to 8,711 shares on January 29, 2021, with respect to 8,712 shares on January 29, 2022, and with respect to 8,739 shares on January 29, 2023, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. /s/ Kelsey Chin, attorney-in-fact 2020-02-06 EX-24 2 attachment1.htm EX-24 DOCUMENT


                                  POWER OF ATTORNEY

     Know all by these presents, that, effective as of  January 29, 2020, the
undersigned hereby constitutes and appoints each of: Marco Pagni, Joseph B.
Amsbary, Jr., Craig Garvey, and Kelsey Chin, respectively, signing singly, the
undersigned's true and lawful attorney-in-fact, with full power of substitution
and resubstitution, to:

     (1)     prepare, execute in the undersigned's name and on the undersigned's
             behalf, and submit to the U.S. Securities and Exchange Commission
             (the "SEC") a Form ID, including amendments thereto, and any other
             documents necessary or appropriate to obtain and renew codes and
             passwords enabling the undersigned to make electronic filings with
             the SEC of reports required by Section 16(a) of the Securities
             Exchange Act of 1934 or any rule or regulation of the SEC;

     (2)     execute for and on behalf of the undersigned, in the undersigned's
             capacity as an officer and/or member of the Board of Directors of
             Walgreens Boots Alliance, Inc. (the "Company"), Forms 3, 4, and 5
             in accordance with Section 16(a) of the Securities Exchange Act of
             1934 and the rules and regulations thereunder;

     (3)     do and perform any and all acts for and on behalf of the
             undersigned which may be necessary or desirable to complete and
             execute any such Form 3, 4, or 5, complete and execute any
             amendment or amendments thereto, and file such form with the SEC
             and any stock exchange or similar authority; and

     (4)     take any other action of any type whatsoever in connection with the
             foregoing which, in the opinion of such attorney-in-fact, may be of
             benefit to, in the best interest of, or legally required by, the
             undersigned, it being understood that the documents executed by
             such attorney-in-fact on behalf of the undersigned pursuant to this
             Power of Attorney shall be in such form and shall contain such
             terms and conditions as such attorney-in-fact may approve in such
             attorney-in-fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 29th day of January, 2020.


                                                /s/ Richard Ashworth
                                                --------------------------------
                                                Signature


                                                Richard Ashworth
                                                --------------------------------
                                                Print Name